Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

A Novel p.L145Q Mutation in the HNF1B Gene in a Case of Maturity-onset Diabetes of the Young Type 5 (MODY5).

Kato T, Tanaka D, Muro S, Jambaljav B, Mori E, Yonemitsu S, Oki S, Inagaki N.

Intern Med. 2018 Jul 15;57(14):2035-2039. doi: 10.2169/internalmedicine.9692-17. Epub 2018 Feb 28.

2.

Challenging Differential Diagnosis of Hypergastremia and Hyperglucagonemia with Chronic Renal Failure: Report of a Case with Multiple Endocrine Neoplasia Type 1.

Murakami T, Usui T, Nakamoto Y, Nakajima A, Mochida Y, Saito S, Shibayama T, Yamazaki N, Hatoko T, Kato T, Yonemitsu S, Muro S, Oki S.

Intern Med. 2017;56(11):1375-1381. doi: 10.2169/internalmedicine.56.7230. Epub 2017 Jun 1.

3.

Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Amyotrophic Lateral Sclerosis in a Patient Developing Carbon Dioxide Narcosis.

Inoue Y, Murakami T, Nakamura T, Morita K, Kaneda D, Nishino I, Hayashi T, Shinoto Y, Hatoko T, Kato T, Yonemitsu S, Muro S, Oki S.

Intern Med. 2017;56(7):797-803. doi: 10.2169/internalmedicine.56.7033. Epub 2017 Apr 1.

4.

Successful Glycemic Control Decreases the Elevated Serum FGF21 Level without Affecting Normal Serum GDF15 Levels in a Patient with Mitochondrial Diabetes.

Murakami T, Ueba Y, Shinoto Y, Koga Y, Kaneda D, Hatoko T, Kato T, Yonemitsu S, Muro S, Oki S.

Tohoku J Exp Med. 2016 Jun;239(2):89-94. doi: 10.1620/tjem.239.89.

5.

Early Onset of Diabetes Mellitus Accelerates Cognitive Decline in Japanese Patients with Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes.

Murakami T, Shinoto Y, Yonemitsu S, Muro S, Oki S, Koga Y, Goto Y, Kaneda D.

Tohoku J Exp Med. 2016 Apr;238(4):311-6. doi: 10.1620/tjem.238.311.

6.

A Novel Missense Mutation of the MEN1 Gene in a Patient with Multiple Endocrine Neoplasia Type 1 with Glucagonoma and Obesity.

Murakami T, Usui T, Nakajima A, Mochida Y, Saito S, Nambu T, Kato T, Matsuda Y, Yonemitsu S, Muro S, Oki S.

Intern Med. 2015;54(19):2475-81. doi: 10.2169/internalmedicine.54.4886. Epub 2015 Oct 1.

7.

Diffuse thyroid enlargement following metastasis of lung adenocarcinoma.

Murakami T, Taki M, Nambu T, Wakasa T, Kato T, Matsuda Y, Yonemitsu S, Muro S, Oki S.

Intern Med. 2015;54(7):807-12. doi: 10.2169/internalmedicine.54.3742. Epub 2015 Apr 1.

8.

Add-on treatment with mitiglinide improves residual postprandial hyperglycemia in type 2 diabetic patients receiving the combination therapy with insulin glargine and sitagliptin.

Murakami T, Nambu T, Kato T, Matsuda Y, Yonemitsu S, Muro S, Oki S.

Tohoku J Exp Med. 2015 Apr;235(4):255-60. doi: 10.1620/tjem.235.255.

9.

Prolonged disturbance of consciousness caused by severe hypophosphatemia: a report of two cases.

Murakami T, Yoshida M, Funazo T, Matsuda Y, Matsuo K, Nambu T, Yonemitsu S, Muro S, Oki S.

Intern Med. 2014;53(19):2227-32.

10.

Desmopressin orally disintegrating tablet in Japanese patients with central diabetes insipidus: a retrospective study of switching from intranasal desmopressin.

Murakami T, Hatoko T, Nambu T, Matsuda Y, Matsuo K, Yonemitsu S, Muro S, Oki S.

Endocr J. 2014;61(8):773-9. Epub 2014 May 20.

11.

Pseudohypoparathyroidism type II in a woman with a history of thyroid surgery.

Murakami T, Nambu T, Morimoto Y, Matsuda Y, Matsuo K, Yonemitsu S, Muro S, Oki S.

Intern Med. 2014;53(7):743-7. Epub 2012 Mar 1.

12.

cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 2 (CRTC2) promotes glucagon clearance and hepatic amino acid catabolism to regulate glucose homeostasis.

Erion DM, Kotas ME, McGlashon J, Yonemitsu S, Hsiao JJ, Nagai Y, Iwasaki T, Murray SF, Bhanot S, Cline GW, Samuel VT, Shulman GI, Gillum MP.

J Biol Chem. 2013 May 31;288(22):16167-76. doi: 10.1074/jbc.M113.460246. Epub 2013 Apr 17.

13.

Liraglutide administration in type 2 diabetic patients who either received no previous treatment or were treated with an oral hypoglycemic agent showed greater efficacy than that in patients switching from insulin.

Nambu T, Matsuda Y, Matsuo K, Kanai Y, Yonemitsu S, Muro S, Oki S.

J Diabetes Investig. 2013 Jan 29;4(1):69-77. doi: 10.1111/j.2040-1124.2012.00242.x. Epub 2012 Sep 7.

14.

Evaluation of the effects of exenatide administration in patients with type 2 diabetes with worsened glycemic control caused by glucocorticoid therapy.

Matsuo K, Nambu T, Matsuda Y, Kanai Y, Yonemitsu S, Muro S, Oki S.

Intern Med. 2013;52(1):89-95. Epub 2013 Jan 1.

15.

The role of the carbohydrate response element-binding protein in male fructose-fed rats.

Erion DM, Popov V, Hsiao JJ, Vatner D, Mitchell K, Yonemitsu S, Nagai Y, Kahn M, Gillum MP, Dong J, Murray SF, Manchem VP, Bhanot S, Cline GW, Shulman GI, Samuel VT.

Endocrinology. 2013 Jan;154(1):36-44. doi: 10.1210/en.2012-1725. Epub 2012 Nov 16.

16.

Distal renal tubular acidosis that became exacerbated by proton pump inhibitor use.

Okamoto N, Nambu T, Matsuda Y, Matsuo K, Osaki K, Kanai Y, Ogawa Y, Yonemitsu S, Kita R, Muro S, Sugawara A, Oki S.

Intern Med. 2012;51(18):2591-5. Epub 2012 Sep 15.

17.

Diabetic ketoacidosis accompanied by hypothermia: a case report.

Nambu T, Mori K, Shinoto Y, Izumi R, Matsuo K, Kanai Y, Kanamoto N, Miura M, Yonemitsu S, Yasoda A, Muro S, Arai H, Oki S, Nakao K.

Diabetes Res Clin Pract. 2012 Jun;96(3):326-30. doi: 10.1016/j.diabres.2012.01.013. Epub 2012 Feb 1.

PMID:
22306059
18.

SirT1 regulates adipose tissue inflammation.

Gillum MP, Kotas ME, Erion DM, Kursawe R, Chatterjee P, Nead KT, Muise ES, Hsiao JJ, Frederick DW, Yonemitsu S, Banks AS, Qiang L, Bhanot S, Olefsky JM, Sears DD, Caprio S, Shulman GI.

Diabetes. 2011 Dec;60(12):3235-45. doi: 10.2337/db11-0616.

19.

Hyperglucagonemia precedes a decline in insulin secretion and causes hyperglycemia in chronically glucose-infused rats.

Jamison RA, Stark R, Dong J, Yonemitsu S, Zhang D, Shulman GI, Kibbey RG.

Am J Physiol Endocrinol Metab. 2011 Dec;301(6):E1174-83. doi: 10.1152/ajpendo.00175.2011. Epub 2011 Aug 23.

20.

Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein.

Erion DM, Ignatova ID, Yonemitsu S, Nagai Y, Chatterjee P, Weismann D, Hsiao JJ, Zhang D, Iwasaki T, Stark R, Flannery C, Kahn M, Carmean CM, Yu XX, Murray SF, Bhanot S, Monia BP, Cline GW, Samuel VT, Shulman GI.

Cell Metab. 2009 Dec;10(6):499-506. doi: 10.1016/j.cmet.2009.10.007.

21.

SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats.

Erion DM, Yonemitsu S, Nie Y, Nagai Y, Gillum MP, Hsiao JJ, Iwasaki T, Stark R, Weismann D, Yu XX, Murray SF, Bhanot S, Monia BP, Horvath TL, Gao Q, Samuel VT, Shulman GI.

Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11288-93. doi: 10.1073/pnas.0812931106. Epub 2009 Jun 22.

22.

The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance.

Nagai Y, Yonemitsu S, Erion DM, Iwasaki T, Stark R, Weismann D, Dong J, Zhang D, Jurczak MJ, Löffler MG, Cresswell J, Yu XX, Murray SF, Bhanot S, Monia BP, Bogan JS, Samuel V, Shulman GI.

Cell Metab. 2009 Mar;9(3):252-64. doi: 10.1016/j.cmet.2009.01.011.

23.

Increased hypothalamic-pituitary-adrenal axis activity and hepatic insulin resistance in low-birth-weight rats.

Buhl ES, Neschen S, Yonemitsu S, Rossbacher J, Zhang D, Morino K, Flyvbjerg A, Perret P, Samuel V, Kim J, Cline GW, Petersen KF.

Am J Physiol Endocrinol Metab. 2007 Nov;293(5):E1451-8. Epub 2007 Sep 25.

24.

The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome.

Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, Yonemitsu S, Cline GW, Befroy D, Zemany L, Kahn BB, Papademetris X, Rothman DL, Shulman GI.

Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12587-94. Epub 2007 Jul 18.

25.

Effect of acute activation of 5'-AMP-activated protein kinase on glycogen regulation in isolated rat skeletal muscle.

Miyamoto L, Toyoda T, Hayashi T, Yonemitsu S, Nakano M, Tanaka S, Ebihara K, Masuzaki H, Hosoda K, Ogawa Y, Inoue G, Fushiki T, Nakao K.

J Appl Physiol (1985). 2007 Mar;102(3):1007-13. Epub 2006 Nov 22.

26.

α2 isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle.

Nakano M, Hamada T, Hayashi T, Yonemitsu S, Miyamoto L, Toyoda T, Tanaka S, Masuzaki H, Ebihara K, Ogawa Y, Hosoda K, Inoue G, Yoshimasa Y, Otaka A, Fushiki T, Nakao K.

Metabolism. 2006 Mar;55(3):300-8.

PMID:
16483872
27.

Possible involvement of the alpha1 isoform of 5'AMP-activated protein kinase in oxidative stress-stimulated glucose transport in skeletal muscle.

Toyoda T, Hayashi T, Miyamoto L, Yonemitsu S, Nakano M, Tanaka S, Ebihara K, Masuzaki H, Hosoda K, Inoue G, Otaka A, Sato K, Fushiki T, Nakao K.

Am J Physiol Endocrinol Metab. 2004 Jul;287(1):E166-73. Epub 2004 Mar 16.

28.

Is an entertainment robot useful in the care of elderly people with severe dementia?

Tamura T, Yonemitsu S, Itoh A, Oikawa D, Kawakami A, Higashi Y, Fujimooto T, Nakajima K.

J Gerontol A Biol Sci Med Sci. 2004 Jan;59(1):83-5.

PMID:
14718491
29.

Troglitazone not only increases GLUT4 but also induces its translocation in rat adipocytes.

Shintani M, Nishimura H, Yonemitsu S, Ogawa Y, Hayashi T, Hosoda K, Inoue G, Nakao K.

Diabetes. 2001 Oct;50(10):2296-300.

30.

Up-regulation of uncoupling protein 3 gene expression by fatty acids and agonists for PPARs in L6 myotubes.

Son C, Hosoda K, Matsuda J, Fujikura J, Yonemitsu S, Iwakura H, Masuzaki H, Ogawa Y, Hayashi T, Itoh H, Nishimura H, Inoue G, Yoshimasa Y, Yamori Y, Nakao K.

Endocrinology. 2001 Oct;142(10):4189-94.

PMID:
11564673
31.

Troglitazone induces GLUT4 translocation in L6 myotubes.

Yonemitsu S, Nishimura H, Shintani M, Inoue R, Yamamoto Y, Masuzaki H, Ogawa Y, Hosoda K, Inoue G, Hayashi T, Nakao K.

Diabetes. 2001 May;50(5):1093-101.

32.

Downregulation of leptin by free fatty acids in rat adipocytes: effects of triacsin C, palmitate, and 2-bromopalmitate.

Shintani M, Nishimura H, Yonemitsu S, Masuzaki H, Ogawa Y, Hosoda K, Inoue G, Yoshimasa Y, Nakao K.

Metabolism. 2000 Mar;49(3):326-30.

PMID:
10726909
33.

Thyrotropin decreases leptin production in rat adipocytes.

Shintani M, Nishimura H, Akamizu T, Yonemitsu S, Masuzaki H, Ogawa Y, Hosoda K, Inoue G, Yoshimasa Y, Nakao K.

Metabolism. 1999 Dec;48(12):1570-4.

PMID:
10599990
34.

Spontaneous remission of primary hyperparathyroidism due to hemorrhagic infarction in the parathyroid adenoma.

Natsui K, Tanaka K, Suda M, Yasoda A, Yonemitsu S, Nakao K.

Intern Med. 1996 Aug;35(8):646-9.

35.

[REGULATION MECHANISM OF THE AUTONOMIC NERVOUS FUNCTIONS. (XXIV) ON THE FUNCTION OF THE NERVUS LARYNIGICUS CRANIALIS INTERNA (N. 1. CR. INT.)].

TOKITA K, KAWAMURA H, OMOTO M, YASHIKI S, OTSUKI T, EBISAWA K, NAKAMURA U, IWANAGA Y, YONEMITSU S, TAGUCHI M, ISHIKAWA E.

Nihon Yakurigaku Zasshi. 1964 Mar 20;60:166-72. Japanese. No abstract available.

PMID:
14156176

Supplemental Content

Loading ...
Support Center